
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur Celso ARANGO |
Documents disponibles écrits par cet auteur (13)



Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention / Ana CATALAN in Journal of Child Psychology and Psychiatry, 62-5 (May 2021)
![]()
[article]
Titre : Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention Type de document : Texte imprimé et/ou numérique Auteurs : Ana CATALAN, Auteur ; Gonzalo SALAZAR DE PABLO, Auteur ; Julio VAQUERIZO SERRANO, Auteur ; Pierluca MOSILLO, Auteur ; Helen BALDWIN, Auteur ; Aranzazu FERNANDEZ-RIVAS, Auteur ; Carmen MORENO, Auteur ; Celso ARANGO, Auteur ; Christoph U CORRELL, Auteur ; Ilaria BONOLDI, Auteur ; Paolo FUSAR-POLI, Auteur Article en page(s) : p.657-673 Langues : Anglais (eng) Mots-clés : Psychosis adolescence childhood clinical high-risk state for psychosis evidence first-episode meta-analysis prediction prevention psychosis risk schizophrenia Index. décimale : PER Périodiques Résumé : BACKGROUND: The clinical high-risk state for psychosis (CHR-P) paradigm has facilitated the implementation of psychosis prevention into clinical practice; however, advancements in adolescent CHR-P populations are less established. METHODS: We performed a PRISMA/MOOSE-compliant systematic review of the Web of Science database, from inception until 7 October 2019, to identify original studies conducted in CHR-P children and adolescents (mean age <18 years). Findings were systematically appraised around core themes: detection, prognosis and intervention. We performed meta-analyses (employing Q statistics and I (2) test) regarding the proportion of CHR-P subgroups, the prevalence of baseline comorbid mental disorders, the risk of psychosis onset and the type of interventions received at baseline. Quality assessment and publication bias were also analysed. RESULTS: Eighty-seven articles were included (n = 4,667 CHR-P individuals). Quality of studies ranged from 3.5 to 8 (median 5.5) on a modified Newcastle-Ottawa scale. Detection: Individuals were aged 15.6 ± 1.2 years (51.5% males), mostly (83%) presenting with attenuated positive psychotic symptoms. CHR-P psychometric accuracy improved when caregivers served as additional informants. Comorbid mood (46.4%) and anxiety (31.4%) disorders were highly prevalent. Functioning and cognition were impaired. Neurobiological studies were inconclusive. PROGNOSIS: Risk for psychosis was 10.4% (95%CI: 5.8%-18.1%) at 6 months, 20% (95%CI: 15%-26%) at 12 months, 23% (95%CI: 18%-29%) at 24 months and 23.3% (95%CI: 17.3%-30.7%) at ?36 months. INTERVENTIONS: There was not enough evidence to recommend one specific treatment (including cognitive behavioural therapy) over the others (including control conditions) to prevent the transition to psychosis in this population. Randomised controlled trials suggested that family interventions, cognitive remediation and fish oil supplementation may improve cognition, symptoms and functioning. At baseline, 30% of CHR-P adolescents were prescribed antipsychotics and 60% received psychotherapy. CONCLUSIONS: It is possible to detect and formulate a group-level prognosis in adolescents at risk for psychosis. Future interventional research is required. En ligne : http://dx.doi.org/10.1111/jcpp.13322 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445
in Journal of Child Psychology and Psychiatry > 62-5 (May 2021) . - p.657-673[article] Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention [Texte imprimé et/ou numérique] / Ana CATALAN, Auteur ; Gonzalo SALAZAR DE PABLO, Auteur ; Julio VAQUERIZO SERRANO, Auteur ; Pierluca MOSILLO, Auteur ; Helen BALDWIN, Auteur ; Aranzazu FERNANDEZ-RIVAS, Auteur ; Carmen MORENO, Auteur ; Celso ARANGO, Auteur ; Christoph U CORRELL, Auteur ; Ilaria BONOLDI, Auteur ; Paolo FUSAR-POLI, Auteur . - p.657-673.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 62-5 (May 2021) . - p.657-673
Mots-clés : Psychosis adolescence childhood clinical high-risk state for psychosis evidence first-episode meta-analysis prediction prevention psychosis risk schizophrenia Index. décimale : PER Périodiques Résumé : BACKGROUND: The clinical high-risk state for psychosis (CHR-P) paradigm has facilitated the implementation of psychosis prevention into clinical practice; however, advancements in adolescent CHR-P populations are less established. METHODS: We performed a PRISMA/MOOSE-compliant systematic review of the Web of Science database, from inception until 7 October 2019, to identify original studies conducted in CHR-P children and adolescents (mean age <18 years). Findings were systematically appraised around core themes: detection, prognosis and intervention. We performed meta-analyses (employing Q statistics and I (2) test) regarding the proportion of CHR-P subgroups, the prevalence of baseline comorbid mental disorders, the risk of psychosis onset and the type of interventions received at baseline. Quality assessment and publication bias were also analysed. RESULTS: Eighty-seven articles were included (n = 4,667 CHR-P individuals). Quality of studies ranged from 3.5 to 8 (median 5.5) on a modified Newcastle-Ottawa scale. Detection: Individuals were aged 15.6 ± 1.2 years (51.5% males), mostly (83%) presenting with attenuated positive psychotic symptoms. CHR-P psychometric accuracy improved when caregivers served as additional informants. Comorbid mood (46.4%) and anxiety (31.4%) disorders were highly prevalent. Functioning and cognition were impaired. Neurobiological studies were inconclusive. PROGNOSIS: Risk for psychosis was 10.4% (95%CI: 5.8%-18.1%) at 6 months, 20% (95%CI: 15%-26%) at 12 months, 23% (95%CI: 18%-29%) at 24 months and 23.3% (95%CI: 17.3%-30.7%) at ?36 months. INTERVENTIONS: There was not enough evidence to recommend one specific treatment (including cognitive behavioural therapy) over the others (including control conditions) to prevent the transition to psychosis in this population. Randomised controlled trials suggested that family interventions, cognitive remediation and fish oil supplementation may improve cognition, symptoms and functioning. At baseline, 30% of CHR-P adolescents were prescribed antipsychotics and 60% received psychotherapy. CONCLUSIONS: It is possible to detect and formulate a group-level prognosis in adolescents at risk for psychosis. Future interventional research is required. En ligne : http://dx.doi.org/10.1111/jcpp.13322 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445 Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies / Laura PINA-CAMACHO in Journal of Autism and Developmental Disorders, 42-7 (July 2012)
![]()
[article]
Titre : Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies Type de document : Texte imprimé et/ou numérique Auteurs : Laura PINA-CAMACHO, Auteur ; Sonia VILLERO, Auteur ; David FRAGUAS, Auteur ; Leticia BOADA, Auteur ; Joost JANSSEN, Auteur ; Francisco J. NAVAS-SANCHEZ, Auteur ; María MAYORAL, Auteur ; Cloe LLORENTE, Auteur ; Celso ARANGO, Auteur ; Mara PARELLADA, Auteur Année de publication : 2012 Article en page(s) : p.1326-1341 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Autistic disorder Asperger syndrome Functional magnetic resonance imaging Diffusion tensor imaging Index. décimale : PER Périodiques Résumé : A systematic review of 208 studies comprising functional magnetic resonance imaging and diffusion tensor imaging data in patients with ‘autism spectrum disorder’ (ASD) was conducted, in order to determine whether these data support the forthcoming DSM-5 proposal of a social communication and behavioral symptom dyad. Studies consistently reported abnormal function and structure of fronto-temporal and limbic networks with social and pragmatic language deficits, of temporo-parieto-occipital networks with syntactic–semantic language deficits, and of fronto-striato-cerebellar networks with repetitive behaviors and restricted interests in ASD patients. Therefore, this review partially supports the DSM-5 proposal for the ASD dyad. En ligne : http://dx.doi.org/10.1007/s10803-011-1360-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=166
in Journal of Autism and Developmental Disorders > 42-7 (July 2012) . - p.1326-1341[article] Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies [Texte imprimé et/ou numérique] / Laura PINA-CAMACHO, Auteur ; Sonia VILLERO, Auteur ; David FRAGUAS, Auteur ; Leticia BOADA, Auteur ; Joost JANSSEN, Auteur ; Francisco J. NAVAS-SANCHEZ, Auteur ; María MAYORAL, Auteur ; Cloe LLORENTE, Auteur ; Celso ARANGO, Auteur ; Mara PARELLADA, Auteur . - 2012 . - p.1326-1341.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 42-7 (July 2012) . - p.1326-1341
Mots-clés : Autism spectrum disorder Autistic disorder Asperger syndrome Functional magnetic resonance imaging Diffusion tensor imaging Index. décimale : PER Périodiques Résumé : A systematic review of 208 studies comprising functional magnetic resonance imaging and diffusion tensor imaging data in patients with ‘autism spectrum disorder’ (ASD) was conducted, in order to determine whether these data support the forthcoming DSM-5 proposal of a social communication and behavioral symptom dyad. Studies consistently reported abnormal function and structure of fronto-temporal and limbic networks with social and pragmatic language deficits, of temporo-parieto-occipital networks with syntactic–semantic language deficits, and of fronto-striato-cerebellar networks with repetitive behaviors and restricted interests in ASD patients. Therefore, this review partially supports the DSM-5 proposal for the ASD dyad. En ligne : http://dx.doi.org/10.1007/s10803-011-1360-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=166 Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy / Aine RODDY ; Martin KNAPP ; Celso ARANGO ; Maria Andreina MENDEZ ; James CUSACK ; Declan MURPHY ; Roberto CANITANO ; Bethany OAKLEY ; Vinciane QUOIDBACH in Journal of Autism and Developmental Disorders, 54-7 (July 2024)
![]()
[article]
Titre : Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy Type de document : Texte imprimé et/ou numérique Auteurs : Aine RODDY, Auteur ; Martin KNAPP, Auteur ; Celso ARANGO, Auteur ; Maria Andreina MENDEZ, Auteur ; James CUSACK, Auteur ; Declan MURPHY, Auteur ; Roberto CANITANO, Auteur ; Bethany OAKLEY, Auteur ; Vinciane QUOIDBACH, Auteur Article en page(s) : p.2733-2741 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children?s families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure. En ligne : https://doi.org/10.1007/s10803-023-05941-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=533
in Journal of Autism and Developmental Disorders > 54-7 (July 2024) . - p.2733-2741[article] Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy [Texte imprimé et/ou numérique] / Aine RODDY, Auteur ; Martin KNAPP, Auteur ; Celso ARANGO, Auteur ; Maria Andreina MENDEZ, Auteur ; James CUSACK, Auteur ; Declan MURPHY, Auteur ; Roberto CANITANO, Auteur ; Bethany OAKLEY, Auteur ; Vinciane QUOIDBACH, Auteur . - p.2733-2741.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 54-7 (July 2024) . - p.2733-2741
Index. décimale : PER Périodiques Résumé : We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children?s families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure. En ligne : https://doi.org/10.1007/s10803-023-05941-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=533 Estimation of the Intelligence Quotient Using Wechsler Intelligence Scales in Children and Adolescents with Asperger Syndrome / Jessica MERCHAN-NARANJO in Journal of Autism and Developmental Disorders, 42-1 (January 2012)
![]()
[article]
Titre : Estimation of the Intelligence Quotient Using Wechsler Intelligence Scales in Children and Adolescents with Asperger Syndrome Type de document : Texte imprimé et/ou numérique Auteurs : Jessica MERCHAN-NARANJO, Auteur ; María MAYORAL, Auteur ; Marta RAPADO-CASTRO, Auteur ; Cloe LLORENTE, Auteur ; Leticia BOADA, Auteur ; Celso ARANGO, Auteur ; Mara PARELLADA, Auteur Année de publication : 2012 Article en page(s) : p.116-122 Langues : Anglais (eng) Mots-clés : Asperger syndrome Intelligence Cognitive profile Wechsler Scales Short forms Dyads Index. décimale : PER Périodiques Résumé : Asperger syndrome (AS) patients show heterogeneous intelligence profiles and the validity of short forms for estimating intelligence has rarely been studied in this population. We analyzed the validity of Wechsler Intelligence Scale (WIS) short forms for estimating full-scale intelligence quotient (FSIQ) and assessing intelligence profiles in 29 AS patients. Only the Information and Block Design dyad meets the study criteria. No statistically significant differences were found between dyad scores and FSIQ scores ( t (28) = 1.757; p = 0.09). The dyad has a high correlation with FSIQ, good percentage of variance explained ( R 2 = 0.591; p < 0.001), and high consistency with the FSIQ classification ( χ 2 (36) = 45.202; p = 0.14). Short forms with good predictive accuracy may not be accurate in clinical groups with atypical cognitive profiles such as AS patients. En ligne : http://dx.doi.org/10.1007/s10803-011-1219-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=151
in Journal of Autism and Developmental Disorders > 42-1 (January 2012) . - p.116-122[article] Estimation of the Intelligence Quotient Using Wechsler Intelligence Scales in Children and Adolescents with Asperger Syndrome [Texte imprimé et/ou numérique] / Jessica MERCHAN-NARANJO, Auteur ; María MAYORAL, Auteur ; Marta RAPADO-CASTRO, Auteur ; Cloe LLORENTE, Auteur ; Leticia BOADA, Auteur ; Celso ARANGO, Auteur ; Mara PARELLADA, Auteur . - 2012 . - p.116-122.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 42-1 (January 2012) . - p.116-122
Mots-clés : Asperger syndrome Intelligence Cognitive profile Wechsler Scales Short forms Dyads Index. décimale : PER Périodiques Résumé : Asperger syndrome (AS) patients show heterogeneous intelligence profiles and the validity of short forms for estimating intelligence has rarely been studied in this population. We analyzed the validity of Wechsler Intelligence Scale (WIS) short forms for estimating full-scale intelligence quotient (FSIQ) and assessing intelligence profiles in 29 AS patients. Only the Information and Block Design dyad meets the study criteria. No statistically significant differences were found between dyad scores and FSIQ scores ( t (28) = 1.757; p = 0.09). The dyad has a high correlation with FSIQ, good percentage of variance explained ( R 2 = 0.591; p < 0.001), and high consistency with the FSIQ classification ( χ 2 (36) = 45.202; p = 0.14). Short forms with good predictive accuracy may not be accurate in clinical groups with atypical cognitive profiles such as AS patients. En ligne : http://dx.doi.org/10.1007/s10803-011-1219-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=151 Longitudinal study of neurological soft signs in first-episode early-onset psychosis / María MAYORAL in Journal of Child Psychology and Psychiatry, 53-3 (March 2012)
![]()
[article]
Titre : Longitudinal study of neurological soft signs in first-episode early-onset psychosis Type de document : Texte imprimé et/ou numérique Auteurs : María MAYORAL, Auteur ; I. BOMBIN, Auteur ; Josefina CASTRO-FORNIELES, Auteur ; Ana GONZALEZ-PINTO, Auteur ; Soraya OTERO, Auteur ; Mara PARELLADA, Auteur ; Dolores MORENO, Auteur ; I. BAEZA, Auteur ; Montserrat GRAELL, Auteur ; Marta RAPADO, Auteur ; Celso ARANGO, Auteur Année de publication : 2012 Article en page(s) : p.323-331 Langues : Anglais (eng) Mots-clés : Neurological soft signs children and adolescents psychosis neurodevelopment Index. décimale : PER Périodiques Résumé : Background: In recent decades, the assessment of neurological soft signs (NSS) in patients with psychosis has become a subject of special interest. The study of the progression of NSS during adolescence will provide valuable information about the role of NSS as endophenotypes or biomarkers and about brain development at a stage in which brain maturation has not yet been completed. Methods: Neurological soft signs were assessed in a sample of 110 first episodes of early-onset psychosis (EOP) and 98 healthy children and adolescents at two different times in a 2-year follow-up period. Results: Patients with EOP showed more NSS than controls both at baseline (p < .001) and the 2-year follow-up (p < .001). No differences were found in the number of signs among the different diagnostic subgroups (schizophrenia, bipolar disorder, and other psychoses). When we examined the changes in NSS over the follow-up, the reduction of NSS in the patients was greater than the controls for ‘Motor coordination’ (p = .032), ‘Others’ (p < .001), and ‘Total score’ (p < .001) of the NES. Conclusion: Despite the greater reduction of NSS in patients than in controls along the follow-up, patients still have more neurological signs than healthy controls; therefore, these signs may be considered a trait marker. NSS do not seem to be specific to schizophrenia as they are present in different EOPs. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2011.02475.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=152
in Journal of Child Psychology and Psychiatry > 53-3 (March 2012) . - p.323-331[article] Longitudinal study of neurological soft signs in first-episode early-onset psychosis [Texte imprimé et/ou numérique] / María MAYORAL, Auteur ; I. BOMBIN, Auteur ; Josefina CASTRO-FORNIELES, Auteur ; Ana GONZALEZ-PINTO, Auteur ; Soraya OTERO, Auteur ; Mara PARELLADA, Auteur ; Dolores MORENO, Auteur ; I. BAEZA, Auteur ; Montserrat GRAELL, Auteur ; Marta RAPADO, Auteur ; Celso ARANGO, Auteur . - 2012 . - p.323-331.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 53-3 (March 2012) . - p.323-331
Mots-clés : Neurological soft signs children and adolescents psychosis neurodevelopment Index. décimale : PER Périodiques Résumé : Background: In recent decades, the assessment of neurological soft signs (NSS) in patients with psychosis has become a subject of special interest. The study of the progression of NSS during adolescence will provide valuable information about the role of NSS as endophenotypes or biomarkers and about brain development at a stage in which brain maturation has not yet been completed. Methods: Neurological soft signs were assessed in a sample of 110 first episodes of early-onset psychosis (EOP) and 98 healthy children and adolescents at two different times in a 2-year follow-up period. Results: Patients with EOP showed more NSS than controls both at baseline (p < .001) and the 2-year follow-up (p < .001). No differences were found in the number of signs among the different diagnostic subgroups (schizophrenia, bipolar disorder, and other psychoses). When we examined the changes in NSS over the follow-up, the reduction of NSS in the patients was greater than the controls for ‘Motor coordination’ (p = .032), ‘Others’ (p < .001), and ‘Total score’ (p < .001) of the NES. Conclusion: Despite the greater reduction of NSS in patients than in controls along the follow-up, patients still have more neurological signs than healthy controls; therefore, these signs may be considered a trait marker. NSS do not seem to be specific to schizophrenia as they are present in different EOPs. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2011.02475.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=152 Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism / Alicia GARCIA-ALCON in Journal of Autism and Developmental Disorders, 53-1 (January 2023)
![]()
PermalinkPharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis / Spyridon SIAFIS in Molecular Autism, 13 (2022)
![]()
PermalinkPlacebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis / Spyridon SIAFIS in Molecular Autism, 11 (2020)
![]()
PermalinkPractitioner Review: Long-term pharmacological treatment of pediatric bipolar disorder / Covadonga M. DIAZ-CANEJA in Journal of Child Psychology and Psychiatry, 55-9 (September 2014)
![]()
PermalinkPsychopathology in Children and Adolescents with ASD Without Mental Retardation / Marta CAAMANO in Journal of Autism and Developmental Disorders, 43-10 (October 2013)
![]()
PermalinkStructural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category / Laura PINA-CAMACHO in Research in Autism Spectrum Disorders, 7-2 (February 2013)
![]()
PermalinkThe affective dimension of early-onset psychosis and its relationship with suicide / Vanessa SANCHEZ-GISTAU in Journal of Child Psychology and Psychiatry, 56-7 (July 2015)
![]()
PermalinkTwo-year diagnostic stability in early-onset first-episode psychosis / Josefina CASTRO-FORNIELES in Journal of Child Psychology and Psychiatry, 52-10 (October 2011)
![]()
Permalink